{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:50:11Z","timestamp":1789973411215,"version":"4.0.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T00:00:00Z","timestamp":1461715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T00:00:00Z","timestamp":1461715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1038\/leu.2016.105","type":"journal-article","created":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T06:42:07Z","timestamp":1461739327000},"page":"1953-1956","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Detection of circulating mast cells in advanced systemic mastocytosis"],"prefix":"10.1038","volume":"30","author":[{"given":"J S","family":"Dahlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J S","family":"Ungerstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Grootens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"G\u00fclen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"H\u00e4gglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,27]]},"reference":[{"key":"BFleu2016105_CR1","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1182\/blood.V94.7.2333.419k30_2333_2342","volume":"94","author":"AS Kirshenbaum","year":"1999","unstructured":"Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott LM, Metcalfe DD . Demonstration that human mast cells arise from a progenitor cell population that is CD34+, c-kit+, and expresses aminopeptidase N (CD13). Blood 1999; 94: 2333\u20132342.","journal-title":"Blood"},{"key":"BFleu2016105_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molimm.2014.01.018","volume":"63","author":"JS Dahlin","year":"2015","unstructured":"Dahlin JS, Hallgren J . Mast cell progenitors: origin, development and migration to tissues. Mol Immunol 2015; 63: 9\u201317.","journal-title":"Mol Immunol"},{"key":"BFleu2016105_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1182\/blood-2015-06-650648","volume":"127","author":"JS Dahlin","year":"2016","unstructured":"Dahlin JS, Malinovschi A, \u00d6hrvik H, Sandelin M, Janson C, Alving K et al. Lin\u2212 CD34hi CD117int\/hi Fc\u025bRI+ cells in human blood constitute a rare population of mast cell progenitors. Blood 2016; 127: 383\u2013391.","journal-title":"Blood"},{"key":"BFleu2016105_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0025-6196(12)62636-6","volume":"61","author":"WD Travis","year":"1986","unstructured":"Travis WD, Li CY, Hoagland HC, Travis LB, Banks PM . Mast cell leukemia: report of a case and review of the literature. Mayo Clin Proc 1986; 61: 957\u2013966.","journal-title":"Mayo Clin Proc"},{"key":"BFleu2016105_CR5","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S0091-6749(96)70133-1","volume":"98","author":"MC Castells","year":"1996","unstructured":"Castells MC, Friend DS, Bunnell CA, Hu X, Kraus M, Osteen RT et al. The presence of membrane-bound stem cell factor on highly immature nonmetachromatic mast cells in the peripheral blood of a patient with aggressive systemic mastocytosis. J Allergy Clin Immunol 1996; 98: 831\u2013840.","journal-title":"J Allergy Clin Immunol"},{"key":"BFleu2016105_CR6","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.1182\/blood-2011-02-335950","volume":"118","author":"S Georgin-Lavialle","year":"2011","unstructured":"Georgin-Lavialle S, Lhermitte L, Baude C, Barete S, Bruneau J, Launay JM et al. Blood CD34\u2212c-Kit+ cell rate correlates with aggressive forms of systemic mastocytosis and behaves like a mast cell precursor. Blood 2011; 118: 5246\u20135249.","journal-title":"Blood"},{"key":"BFleu2016105_CR7","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/leu.2015.16","volume":"29","author":"A Pardanani","year":"2015","unstructured":"Pardanani A, Lasho T, Chen D, Kimlinger TK, Finke C, Zblewski D et al. Aberrant expression of CD123 (interleukin-3 receptor-alpha) on neoplastic mast cells. Leukemia 2015; 29: 1605\u20131608.","journal-title":"Leukemia"},{"key":"BFleu2016105_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","volume":"25","author":"P Valent","year":"2001","unstructured":"Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001; 25: 603\u2013625.","journal-title":"Leuk Res"},{"key":"BFleu2016105_CR9","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/ajh.21713","volume":"85","author":"AR Arredondo","year":"2010","unstructured":"Arredondo AR, Gotlib J, Shier L, Medeiros B, Wong K, Cherry A et al. Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge. Am J Hematol 2010; 85: 600\u2013606.","journal-title":"Am J Hematol"},{"key":"BFleu2016105_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jmoldx.2010.10.004","volume":"13","author":"T Kristensen","year":"2011","unstructured":"Kristensen T, Vestergaard H, Moller MB . Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay. J Mol Diagn 2011; 13: 180\u2013188.","journal-title":"J Mol Diagn"},{"key":"BFleu2016105_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0145-2126(01)00041-8","volume":"25","author":"WR Sperr","year":"2001","unstructured":"Sperr WR, Escribano L, Jordan JH, Schernthaner GH, Kundi M, Horny HP et al. Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis. Leuk Res 2001; 25: 529\u2013536.","journal-title":"Leuk Res"},{"key":"BFleu2016105_CR12","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736","volume":"91","author":"L Escribano","year":"1998","unstructured":"Escribano L, Orfao A, Diaz-Agustin B, Villarrubia J, Cervero C, Lopez A et al. Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. Blood 1998; 91: 2731\u20132736.","journal-title":"Blood"},{"key":"BFleu2016105_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0301-472X(99)00145-9","volume":"28","author":"C Akin","year":"2000","unstructured":"Akin C, Kirshenbaum AS, Semere T, Worobec AS, Scott LM, Metcalfe DD . Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis. Exp Hematol 2000; 28: 140\u2013147.","journal-title":"Exp Hematol"},{"key":"BFleu2016105_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ajh.2830340409","volume":"34","author":"E Torrey","year":"1990","unstructured":"Torrey E, Simpson K, Wilbur S, Munoz P, Skikne B . Malignant mastocytosis with circulating mast cells. Am J Hematol 1990; 34: 283\u2013286.","journal-title":"Am J Hematol"},{"key":"BFleu2016105_CR15","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/annonc\/mdu047","volume":"25","author":"P Valent","year":"2014","unstructured":"Valent P, Sotlar K, Sperr WR, Escribano L, Yavuz S, Reiter A et al. Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal. Ann Oncol 2014; 25: 1691\u20131700.","journal-title":"Ann Oncol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2016105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2016105","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2016105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:07:01Z","timestamp":1648742821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2016105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,27]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["BFleu2016105"],"URL":"https:\/\/doi.org\/10.1038\/leu.2016.105","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,27]]},"assertion":[{"value":"27 April 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}